Eli Lilly & Co.'s COVID-19 antibody treatment was approved for emergency use by the Food and Drug Administration on Monday, and Lilly shares jumped more than 3% in after-hours trading.

from MarketWatch.com - Top Stories https://ift.tt/35f0I5h
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/35f0I5h
via IFTTT
Kommentare
Kommentar veröffentlichen